Our Team
Executive Director
Ulrich Krasilnikoff
CEO & CFO - Board Member
Education and experience: Born 1967, MBA – SDU, Dipl. Ing – DTU, B.Sc. in finance and accounting – CBS, Certified Public Accountant – CBS/PWC.
- EVP Biofac Group (pharma; 2015-2016)
- Ass. Partner Capidea Capital Fund (Private equity; 2012-2014)
- Partner/EVP Mezzanin Capital/Kirk & Thorsen (Private equity; 2004-2012)
- EVP HNC Group A/S (2002-2004)
- Board member; Carl Hansen & Søn, AH Metal Solutions and other companies.
Ulrich Krasilnikoff is a member of the Board of Directors of Curasight A/S as well as being CEO and CFO of the company since 2016. He holds an MBA, Diploma Engineering and a B.Sc. in Finance and Accounting and is also a certified public accountant. In the years 2015-2016, he was Executive Vice President of BIOFAC Group which specializes in manufacturing of products for the pharmaceutical, veterinary and the nutraceutical industries. Furthermore, he has more than 10 years’ experienceas partner in the private equity industry, besides he is member of the Board of Carl Hansen & Søn, Primodan, AH Metal Solutions and has previously been a member of the Board of other techcompanies.
Andreas Kjær
CSO and co-founder (2013), Board member
Education and experience: Born 1963, MD, PhD, DMSc, MBA and professor at the University of Copenhagen and chief physician at Rigshospitalet, the National University Hospital of Denmark.
- His research is focused on molecular imaging with PET and PET/MRI and theranostics in cancer.
- His achievements include development of several new tracers that have reached first-in-humans clinical use.
- He is the holder of an ERC Advanced Grant, has published more than 500 peer-review articles and has received numerous prestigious scientific awards over the years.
- He is a member of the Danish Academy of Technical Sciences.
Andreas Kjæris co-founder of Curasight A/S, CSO and member of the Board of Directors of the company. From the University of Copenhagen, he has obtained an MD, PhD, DMSc and an MBA for Copenhagen Business School. He is a professor at University of Copenhagen and a chief physician at Rigshospitalet, and head of Cluster for Molecular Imaging His research is focused on molecular imaging with PET, PET/MRI and theranostics in cancer. He has published more than 500 peer-reviewed articles, has received numerous scientific awards and is the holder of an ERC Advanced Grant. He is also a member of the Danish Academy of Technical Sciences, which is a non-profit organization that strives to make Denmark a leading region within Science & Engineering.
